Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 19 November 2008. doi:10.1136/ard.2008.099481
Annals of the Rheumatic Diseases 2009;68:1781-1786
Copyright © 2009 BMJ Publishing Group Ltd & European League Against Rheumatism.

BASIC AND TRANSLATIONAL RESEARCH

Extended report

Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis

J C-C Wei1,2, H-S Lee3,4, W-C Chen3, L-J Shiu4, S-F Yang5, R-H Wong3,4,6

1 Department of Medicine, Chung Shan Medical University, Taichung, Taiwan
2 Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan
3 Department of Public Health, College of Health Care and Management, Chung Shan Medical University, Taichung, Taiwan
4 Institute of Public Health, College of Health Care and Management, Chung Shan Medical University, Taichung, Taiwan
5 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
6 Institute of Medical and Molecular Toxicology, Chung Shan Medical University, Taichung, Taiwan

Correspondence to Dr R-H Wong, Department of Public Health, Chung Shan Medical University, 110 Chien-Kuo N Rd, Sec 1, Taichung, Taiwan 40242; rueyhong{at}csmu.edu.tw

Background: The aetiology of ankylosing spondylitis (AS) remains unclear. Inflammation progresses to fibrosis and calcification of the spine and sacroiliac joints in AS development. Fibrosis results from excessive accumulations of the extracellular matrix (ECM). ECM turnover depends on the balance between matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs).

Objective: To evaluate the effects of the MMP-3 -1171 and TIMP-1 372 T>C polymorphisms on the modified risk of AS.

Methods: Genotypes of 241 patients with AS and 241 controls were identified by PCR. Disease activity and functional status were assessed by the Bath Ankylosing Spondylitis Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Bath Ankylosing Spondylitis Global (BAS-G) Score.

Results: MMP-3 6A/6A carriers had a 2.41-fold (95% confidence interval (CI) 1.55 to 3.74) increased risk of AS compared with 6A/5A and 5A/5A carriers. TIMP-1 C alleles had a greater risk of AS, but this was not significant (odds ratio (OR) = 1.28, 95% CI 0.92 to 1.77). Pairwise analysis of the MMP-3/TIMP-1 alleles showed that 6A/C (OR = 3.23, 95% CI 1.50 to 6.95) and 6A/T (OR = 2.55, 95% CI 1.17 to 5.54) had a significantly greater risk of AS than the 5A/T alleles. After adjustment for the effects of age, gender and disease duration, the MMP-3/TIMP-1 5A/T alleles had the lowest BASDAI (p = 0.02), BASFI (p = 0.05) and BAS-G (p = 0.02) among all MMP-3/TIMP-1 alleles.

Conclusion: The findings highlight the importance of the MMP-3 and TIMP-1 genes as crucial elements in AS development.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs